Impact of immune checkpoint inhibitors on the management of locally advanced or metastatic non-small cell lung cancer in real-life practice in patients initiating treatment between 2015 and 2018 in France and Germany. 4. November 2022 F Griesinger, M Pérol, N Girard, I Durand-Zaleski, S Zacharias, L Bosquet, M Jänicke, X Quantin, A Groth, A Fleitz, A Calleja, S Patel, L Lacoin, M J Daumont, J R Penrod, R Carroll, D Waldenberger, D Reynaud, M Thomas, C Chouaid, 2022. Lung Cancer, Volume 172, 2022, Pages 65-74. https://doi.org/10.1016/j.lungcan.2022.08.001. Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients. Hillebrand L, E, Söling U, Marschner N, 2022. Oncol Res Treat 2022;45:423-429. doi: 10.1159/000521826… Weiterlesen Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR. C Geßner, T Fietz, C Losem, A Lück, H Schulz, B Niemeier, M Groschek, H Eschenburg, R Weide, A Kretzschmar, N Frost, J Hipp, J… Weiterlesen